A major new update for Borderlands 4 has today been released, and it’s one of the biggest the game has seen so far in 2026.

Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...

Recursion is more than a coding trick—it’s a powerful way to simplify complex problems in Python. From elegant tree traversals to backtracking algorithms, mastering recursion opens the door to cleaner ...

The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...

Smart Robotics secures €10M Series A funding to expand its AI-powered robotic picking solutions across Europe, boosting ...

Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen ...

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...